Bank of New Hampshire Raises Holdings in The Clorox Company (NYSE:CLX)

Bank of New Hampshire boosted its stake in shares of The Clorox Company (NYSE:CLX) by 14.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,090 shares of the company’s stock after acquiring an additional 260 shares during the period. Bank of New Hampshire’s holdings in Clorox were worth $298,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Modera Wealth Management LLC boosted its holdings in shares of Clorox by 1.4% during the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock worth $672,000 after purchasing an additional 71 shares during the last quarter. First National Bank of Mount Dora Trust Investment Services boosted its holdings in shares of Clorox by 3.2% during the fourth quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock worth $322,000 after purchasing an additional 71 shares during the last quarter. Czech National Bank boosted its holdings in Clorox by 0.3% in the fourth quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after acquiring an additional 71 shares during the last quarter. Global Retirement Partners LLC boosted its holdings in Clorox by 7.2% in the fourth quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock valued at $156,000 after acquiring an additional 73 shares during the last quarter. Finally, Blue Trust Inc. boosted its holdings in Clorox by 12.4% in the fourth quarter. Blue Trust Inc. now owns 698 shares of the company’s stock valued at $91,000 after acquiring an additional 77 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 0.2 %

Shares of NYSE CLX traded down $0.28 during midday trading on Thursday, reaching $147.50. 1,112,612 shares of the company’s stock were exchanged, compared to its average volume of 1,203,883. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21. The stock has a market capitalization of $18.31 billion, a PE ratio of 234.59, a price-to-earnings-growth ratio of 2.31 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The business’s fifty day moving average price is $149.59 and its two-hundred day moving average price is $142.27.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.98 earnings per share. Analysts forecast that The Clorox Company will post 5.52 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 annualized dividend and a yield of 3.25%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 761.92%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of research analyst reports. Barclays reduced their target price on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. UBS Group lifted their target price on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.